A virtual campus to accelerate drug discovery through artificial intelligence
The pharmaceutical laboratories Servier and Oncodesign Precision Medicine (OPM), a biopharmaceutical company specializing in the treatment of resistant and metastatic cancers, are launching “FederAidd” (Federation for Artificial Intelligence in Drug Discovery), an international virtual campus of open innovation to accelerate and make the drug discovery process more reliable thanks to artificial intelligence. A webinar will … Read more